{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "18799026", "DateCompleted": {"Year": "2010", "Month": "08", "Day": "31"}, "DateRevised": {"Year": "2015", "Month": "03", "Day": "13"}, "Article": {"ArticleDate": [], "Language": ["chi"], "ELocationID": [], "Journal": {"JournalIssue": {"Volume": "27", "Issue": "9", "PubDate": {"Year": "2008", "Month": "Sep"}}, "Title": "Ai zheng = Aizheng = Chinese journal of cancer", "ISOAbbreviation": "Ai Zheng"}, "ArticleTitle": "[Antitumor effects of raddeanin A on S180, H22 and U14 cell xenografts in mice].", "Pagination": {"StartPage": "910", "EndPage": "913", "MedlinePgn": "910-3"}, "Abstract": {"AbstractText": ["Raddeanin A, a triterpenoid saponin from Anemone raddeana Regel, has good antitumor activity in vitro. This study was to investigate its antitumor effects on tumor cell xenografts in mice.", "The inhibitory effects of raddeanin A on the proliferation of human nasopharyngeal carcinoma KB cells and ovarian cancer SKOV3 cells were measured by MTT assay. The inhibitory effects of raddeanin A injection on the growth of sarcoma S180, liver cancer H22 and cervical carcinoma U14 cell xenografts in mice and the effect of raddeanin A lavage on the growth of S180 cell xenografts were measured. The acute toxicity of raddeanin A was also measured.", "The 50% inhibition concentration (IC(50)) of raddeanin A was 4.64 microg/mL for KB cells and 1.40 microg/mL for SKOV3 cells. When injected with raddeanin A at a dose of 4.5 mg/kg, the growth inhibition rates of S180, H22 and U14 cell xenografts were 60.5%, 36.2% and 61.8%, respectively. When lavaged with raddeanin A at a dose of 200 mg/kg, the growth inhibition rate of S180 cell xenografts was 64.7%. The median lethal dose (LD50) of raddeanin A lavage was 1.1 g/kg and that of raddeanin A injection was 16.1 mg/kg.", "Raddeanin A has good antitumor activity both in vitro and in vivo, and would be a potential antitumor medicine."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Natural Product Research Center, Chengdu Institute of Biology, Chinese Academy of Sciences, Chengdu, Sichuan, 610041, PR China. wangmk@cib.ac.cn"}], "Identifier": [], "LastName": "Wang", "ForeName": "Ming-Kui", "Initials": "MK"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ding", "ForeName": "Li-Sheng", "Initials": "LS"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Feng-E", "Initials": "FE"}], "PublicationTypeList": ["English Abstract", "Journal Article"]}, "MedlineJournalInfo": {"Country": "China", "MedlineTA": "Ai Zheng", "NlmUniqueID": "9424852"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents, Phytogenic"}, {"RegistryNumber": "0", "NameOfSubstance": "Drugs, Chinese Herbal"}], "MeshHeadingList": [{"QualifierName": ["chemistry"], "DescriptorName": "Anemone"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Antineoplastic Agents, Phytogenic"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": ["drug effects"], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["isolation & purification", "pharmacology", "toxicity"], "DescriptorName": "Drugs, Chinese Herbal"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pathology"], "DescriptorName": "Liver Neoplasms, Experimental"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred ICR"}, {"QualifierName": ["pathology"], "DescriptorName": "Nasopharyngeal Neoplasms"}, {"QualifierName": [], "DescriptorName": "Neoplasm Transplantation"}, {"QualifierName": ["pathology"], "DescriptorName": "Ovarian Neoplasms"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Random Allocation"}, {"QualifierName": ["pathology"], "DescriptorName": "Sarcoma 180"}, {"QualifierName": ["drug effects"], "DescriptorName": "Tumor Burden"}, {"QualifierName": ["pathology"], "DescriptorName": "Uterine Cervical Neoplasms"}, {"QualifierName": [], "DescriptorName": "Xenograft Model Antitumor Assays"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2008", "Month": "9", "Day": "19", "Hour": "9", "Minute": "0"}, {"Year": "2010", "Month": "9", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2008", "Month": "9", "Day": "19", "Hour": "9", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["18799026", "1000-467X200809910"]}}], "PubmedBookArticle": []}